USCA RIA’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | $3.95M | Buy |
17,217
+483
| +3% | +$97K | 0.24% | 121 |
|
|
2021
Q1 | $3.13M | Buy |
16,734
+12,921
| +339% | +$2.53M | 0.21% | 148 |
|
|
2020
Q4 | $644K | Buy |
3,813
+21
| +0.6% | +$3.13K | 0.05% | 291 |
|
|
2020
Q3 | $561K | Sell |
3,792
-11
| -0.3% | -$1.7K | 0.04% | 274 |
|
|
2020
Q2 | $624K | Buy |
3,803
+224
| +6% | +$34.4K | 0.06% | 259 |
|
|
2020
Q1 | $496K | Sell |
3,579
-100
| -3% | -$13.7K | 0.06% | 265 |
|
|
2019
Q4 | $484K | Hold |
3,679
| – | – | 0.04% | 328 |
|
|
2019
Q3 | $411K | Buy |
+3,679
| New | +$410K | 0.04% | 332 |
|
|
2019
Q2 | – | Sell |
-1,753
| Closed | -$227K | – | 469 |
|
|
2019
Q1 | $227K | Sell |
1,753
-219
| -11% | -$26.6K | 0.02% | 387 |
|
|
2018
Q4 | $228K | Sell |
1,972
-437
| -18% | -$48.8K | 0.03% | 371 |
|
|
2018
Q3 | $259K | Sell |
2,409
-22,332
| -90% | -$2.23M | 0.03% | 404 |
|
|
2018
Q2 | $2.11M | Buy |
24,741
+58
| +0.2% | +$4.76K | 0.23% | 143 |
|
|
2018
Q1 | $1.91M | Sell |
24,683
-596
| -2% | -$48K | 0.21% | 138 |
|
|
2017
Q4 | $2.13M | Buy |
25,279
+17,738
| +235% | +$1.51M | 0.24% | 122 |
|
|
2017
Q3 | $621K | Hold |
7,541
| – | – | 0.08% | 247 |
|
|
2017
Q2 | $621K | Buy |
+7,541
| New | +$615K | 0.08% | 248 |
|
|
2016
Q4 | – | Sell |
-2,701
| Closed | -$217K | – | 390 |
|
|
2016
Q3 | $217K | Hold |
2,701
| – | – | 0.04% | 346 |
|
|
2016
Q2 | $213K | Buy |
+2,701
| New | +$203K | 0.04% | 337 |
|
|
2016
Q1 | – | Sell |
-2,540
| Closed | -$214K | – | 379 |
|
|
2015
Q4 | $214K | Hold |
2,540
| – | – | 0.05% | 330 |
|
|
2015
Q3 | $213K | Hold |
2,540
| – | – | 0.05% | 318 |
|
|
2015
Q2 | $212K | Sell |
2,540
-675
| -21% | -$51.4K | 0.06% | 310 |
|
|
2015
Q1 | $234K | Sell |
3,215
-100
| -3% | -$7.12K | 0.06% | 296 |
|
|
2014
Q4 | $229K | Buy |
+3,315
| New | +$224K | 0.06% | 286 |
|
|
2014
Q3 | – | Sell |
-19,229
| Closed | -$1.2M | – | 336 |
|
|
2014
Q2 | $1.2M | Buy |
19,229
+227
| +1% | +$13.5K | 0.4% | 68 |
|
|
2014
Q1 | $1.12M | Sell |
19,002
-9,214
| -33% | -$514K | 0.4% | 70 |
|
|
2013
Q4 | $1.44M | Buy |
28,216
+4,061
| +17% | +$203K | 0.57% | 44 |
|
|
2013
Q3 | $1.22M | Buy |
24,155
+7,452
| +45% | +$390K | 0.55% | 52 |
|
|
2013
Q2 | $820K | Buy |
+16,703
| New | +$909K | 0.41% | 64 |
|
Other funds holding LLY
USCA RIA's LLY Position: Q2 2021 in Review
USCA RIA increased its Eli Lilly (LLY) stake by 2.9% in Q2 2021, buying an estimated $97K and bringing the position to 17,217 shares worth $3.95M. The position accounts for 0.24% of the portfolio, ranked #121.
USCA RIA first reported a position in LLY in Q2 2013 and has held it in 28 quarters since. 2,021 funds tracked by Wall St. Rank hold LLY as of Q2 2021.
- USCA RIA held 17,217 shares of Eli Lilly worth $3.95M as of Q2 2021.
- USCA RIA bought 483 Eli Lilly shares in Q2 2021, an estimated $97K.
- Eli Lilly made up 0.24% of USCA RIA's portfolio in Q2 2021, its #121 holding.
- USCA RIA first reported a position in Eli Lilly in Q2 2013 and has held it in 28 quarters since.
- 2,021 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2021.
Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.